This trial looks at ways to improve the quality of livers used in transplants for patients with liver cancer, known as hepatocellular carcinoma (HCC). After a liver transplant, some patients may experience cancer returning. The researchers want to see if using a special method called hypothermic oxygenated perfusion (HOPE) can help patients live longer without the cancer coming back compared to the standard method of cold storage. The trial involves patients from transplant centers around the world and will include 220 participants over 12 months, followed by at least two years of observation.
The trial’s ID number is NCT06717919. It is a Phase 4 trial, which means it is looking at how well the treatment works and how safe it is. The trial is not regulated by the FDA and plans to include about 220 participants.
Who can join
Adults over 18 years who are waiting for a liver transplant due to HCC can join. They need to have a specific type of liver cancer and should be able to give informed consent. Some people will not be able to join, including those with certain types of liver grafts or cancers, and those who are pregnant. The trial team will check each person's eligibility.
Conditions
Liver Transplantation, HCC, Oncological Outcomes
Age group
Adult, Older adult
Sex
All sexes
The study team makes the final call on eligibility.
What happens in the study
Participants will be randomly placed into two groups. One group will receive livers that have been treated with hypothermic oxygenated perfusion (HOPE). The other group will receive livers stored in the traditional cold storage method. Everyone will be monitored for outcomes after their transplant.
Where
This trial is enrolling at 2 locations. Recruiting sites are listed first.
Led global trials in liver and bile duct cancer. Treats pancreatic cancer, gallbladder cancer, bile duct cancer and liver cancer. Offers targeted therapy.
Directs genitourinary oncology at Huntsman Cancer Institute. Treats pancreatic cancer, liver cancer, gallbladder cancer and esophageal cancer. Also treats stomach cancer and colorectal cancer.
A surgeon who treats colorectal cancer and stomach cancer at Cancer Institute Hospital of JFCR. Treats colorectal cancer, stomach cancer, esophageal cancer and pancreatic cancer. Also treats liver cancer.